Weekly Psychedelic Links - June 2022

6.3.22

Cannabis

• Virginia: Approved Budget Recriminalizes Public Marijuana Possession Over Four Ounces of Marijuana (NORML)

• Connecticut Gov. signs bill to crack down on weed gifting (Leafly)

• North Carolina Senate Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Study Finds THC Detected in Blood or Breath Does Not Indicate Impairment (High Times)

• Medicinal cannabis reduces pain and the need for opiate painkillers among cancer patients (PsyPost)

• North Carolina Lawmakers Advance Bill To Make Hemp Permanently Legal (High Times)

• With veto, path to marijuana legalization in Delaware still open but fraught with unpredictability (WHYY)

• FBI Marijuana Arrest Data May Be Critically Flawed, And DOJ Is Being Asked To Investigate (Marijuana Moment)

• Louisiana Senate Approves Bill Allowing Public Employees to Use Medical Pot (High Times)

• New York Senate Passes Gray Market Cannabis Bill (High Times)

• Legal Cannabis Use Could Disqualify White House Intern Applicants (Forbes)

• Texas Activists Say They Collected Enough Signatures To Put Marijuana Decriminalization On Another City Ballot (Marijuana Moment)

• Gen Z Prefers Weed Over Booze (High Times)

• Marijuana Research Has Exploded In Recent Years Despite Barriers Caused By Prohibition, New Study Finds (Marijuana Moment)

• Peru Issues Draft Law to Allow and Regulate Patient-Grown Medical Cannabis (High Times)

• New York Senate Approves Bill To Mandate Medical Marijuana Health Insurance Coverage (Marijuana Moment)

• Austria Imports Record Amount of Medical Weed While Constitutional Challenges Loom (High Times)

• Weed Joke on Jeopardy! Triggers Viewers (High Times)

LSD

• Neuroscientists gain a deeper understanding of how LSD affects molecular brain activity (PsyPost)

• Ceruvia Lifesciences to Supply LSD to Qualified Researchers at No Cost (PR Newswire)

Magic Mushrooms

• Oregon Officials’ Rejection Of Rules For Spiritual And Religious Psilocybin Use Called Into Question (Marijuana Moment)

• In Algeria, Ancient Cave Art May Show Psychedelic Mushroom Use (Atlas Obscura)

• New studies shed light on the mysterious process by which psilocybin can rapidly improve depression symptoms (PsyPost)

• B.C. company opens Canada's largest licensed psychedelic mushroom growing facility (CBC)

• Policy and Legal Considerations for Religious and Community Use of Psilocybin Mushrooms under Oregon Measure 109 (Chacruna)

MDMA

• A Balm for Psyches Scarred by War (The New York Times)

• 'Highly unusual': Methamphetamine found in MDMA tablets for the first time in New Zealand (Stuff.co.nz)

Peyote

• The Navajo Nation to Protect the Sanctity of Azeé – Peyote Medicine from Legalization and Commercial Use (Chacruna)

Nitrous Oxide

• Warning over climate threat from laughing gas used during childbirth (Sydney Morning Herald)

• Linking nitrous oxide to climate risk is yet another example of the disdain shown to women’s pain (The Guardian)

Ketamine

• Ketamine can treat depression — but teletherapy could make it accessible (Inverse)

Miscellaneous

• Canada to decriminalize some drugs in British Columbia for three years (The Guardian)

• Maryland Bill To Fund Psychedelics Research And Access For Veterans Takes Effect Without Governor’s Signature (Marijuana Moment)

• DARE 2.0 is "Keepin' it Real" in US schools (Substance)

• Indigenous and drug policy groups seek to preserve traditional approaches as psychedelic markets open in Oregon (OPB)

• Michigan Activists Give Up 2022 Push For Psychedelics Legalization Ballot Initiative, Shifting Focus To 2024 (Marijuana Moment)

• The Intertwined Prohibitionist Histories of Psychedelics and Kratom (Psychedelics Today)

• Why this startup is encouraging employees to microdose psychedelics at work (Fast Company)

• From Psychedelic Pharma To Crop Gene Editing - The UK’s Big Opportunity (Forbes)

• Don’t Count on RFRA to Protect Psychedelic Churches (Lucid News)

• Tripping over the potential of psychedelics for autism (Spectrum)

• Understanding the Current Legal Status of Psychedelics in the United States (JD Supra)

• Can you take the trip out of psychedelics and still treat depression? (New Scientist)

6.10.22

Cannabis

• Thailand legalises cannabis trade but still bans recreational use (BBC)

• Prescription cannabis products with more THC may ease chronic pain, at least a little, study finds (CNN)

• North Carolina Senate Passes Medical Marijuana Bill To House, But Questions Loom About Further Action This Year (Marijuana Moment)

• Delaware: Lawmakers Decline to Overturn Cannabis Legalization Veto (NORML)

• Voters In Five Texas Cities Will Decide On Marijuana Decriminalization In November, Activists Say (Marijuana Moment)

• Louisiana Legislature Passes Bill to Protect State Workers from Termination for Medical Cannabis (Ganjapreneur)

• Portugal Group Demands Freedom to Vote for Personal Use of Cannabis (High Times)

• The Rapidly Expanding Cannabis Industry Needs To Get Its Marketing Act Together, A New Report Finds (Forbes)

• If you’re high your love life might not be as great as you think (New York Post)

• Ukraine to Legalize Medical Cannabis, Health Minister Says (High Times)

• Illinois Governor Signs Bill To Close Marijuana Expungement ‘Loophole’ (Marijuana Moment)

• Inflation’s so insane Snoop Dogg gave his blunt roller a raise (Leafly)

• Legal Cannabis Use Could Disqualify White House Intern Applicants (Forbes)

• West Virginia Activists Are Collecting Signatures To Put Marijuana Decriminalization Measures On Local Ballots (Marijuana Moment)

• Medical Cannabis & Sleep Disorders: What Do We Really Know? (The Fresh Toast)

• Is the word ‘marijuana’ racist? (Leafly)

• Opening the Curtain on Cannabis in the Opera (High Times)

LSD

• LSD microdosing does not appear to improve mood or cognitive ability, according to new placebo-controlled study (PsyPost)

Magic Mushrooms

• Clinical Trial in South Africa to Study Efficacy of Psilocybin on Women with HIV and Depression (High Times)

MDMA

• Colorado Governor Signs Bill To Legalize MDMA Prescriptions Pending Federal Approval (Marijuana Moment)

• Brexit helping cause harmful increase in fake ecstasy, study warns (The Guardian)

Ayahuasca

• I Tried Everything. Then I Tried Ayahuasca. (Esquire)

Miscellaneous

• Psychedelic Pharma’s Big Spin (Lucid News)

• The Nationwide Reach of Harmful Drug “Paraphernalia” Laws (Filter)

• Tracing The History of Hallucinogens in China (TalkingDrugs)

• How psychedelic drugs might treat depression (BBC)

• Bosses want to feed psychedelics to their staff (The Economist)

• The Great Cannabis Microdosing PR Conspiracy (High Times)

6.17.22

Cannabis

• Germany set to legalise sale of cannabis in licensed shops (Metro)

• Study Finds Weekly Cannabis Use Has Minimal Impairment on Physical Health (High Times)

• How cannabis-fed chickens may help cut Thai farmers’ antibiotic use (The Guardian)

• Analysis: Cannabis Retailers Drive Economic Growth, Are Not Magnets for Crime (NORML)

• Maine’s Legal Marijuana Stores Are Effectively Displacing Illicit Market, State Report Finds (Marijuana Moment)

• New Zealand Leaders Demand Cops Stop Spraying Chemicals on Cannabis (High Times)

• Study: Regular Cannabis Consumers Perform Better Than Occasional Users on Distracted Driving Tasks (NORML)

• Kentucky Governor Issues Medical Marijuana Executive Order Creating Advisory Committee To Study Patient Access Options (Marijuana Moment)

• Study Shows Medical Cannabis Enrollment Has Quadrupled (High Times)

• EPA Warns Workers They’re Banned From Using Marijuana Or Investing In The Industry In New Memo (Marijuana Moment)

• DEA Reports Significant Uptick in Marijuana-Related Seizures, Arrests (NORML)

• Athens, Georgia on Cusp of Major Decriminalization Ordinance (High Times)

• Teen Marijuana Use Dropped Dramatically In Colorado In 2021, State Study Finds (Marijuana Moment)

• New Mexico Lawsuit Seeks Insurance Coverage for Medical Cannabis (High Times)

• GOP Senate Candidate Pushes ‘Pot For Potholes’ Marijuana-Funded Infrastructure Plan In Hilarious Campaign Ad (Marijuana Moment)

• Superior Court in Brazil Affirms Right to Cannabis Home Grow (High Times)

• Federal Court Sides With Nebraska Medical Marijuana Activists In Lawsuit Over Ballot Requirements (Marijuana Moment)

• West Virginia Advocates Collecting Signatures for Decriminalization Ballot Measures (High Times)

LSD

• The Elephant in the Room is LSD (Lucid News)

Magic Mushrooms

• Psilocybin-induced mystical experiences linked to lasting positive psychological effects (PsyPost)

• Anticipating Legalization: Making Psilocybin Accessible (Cannabis Science and Technology)

• Could magic mushrooms in care homes help curb fear of death? Psychedelic drugs could 'revolutionise' end-of-life treatment, expert says (Daily Mail)

MDMA

• Paraguay May Be Shifting from Producing LSD and MDMA to Consuming Them (InSight Crime)

5-MeO-DMT

• What’s the Best Way To Take 5-MeO-DMT in a Clinical Trial? (Technology Networks)

Iboga

• Ibogaine Isn’t a “Cure” for Addiction—But It Can Be a Useful Detox Tool (Filter)

Synthetic Cannabinoids

• Oregon ban on synthetic cannabis products will be nation’s first (Oregon Live)

Ketamine

• Exploring Ketamine’s Antimicrobial Effects & Fungal Sources: Part 1 (Psychedelic Science Review)

• The 'normalised' drug that the UK takes more of than any other country (Liverpool Echo)

Miscellaneous

• Mind-Altering Drug Docuseries Lined Up At Netflix From Alex Gibney & Michael Pollan (Deadline)

• Malaysia Ends Mandatory Death Penalty for Nonviolent Drug Crimes (High Times)

• Is drug testing going to become a regular part of UK festivals? (iTV)

• Missoula City Council measure would decriminalize hallucinogenic plants (Missoula Current)

• Local Psychedelics Decriminalization Measure Stalls In Amherst, Massachusetts (Marijuana Moment)

• The abuse of power in psychedelic retreats (leafie)

• Psychedelics Can Help Boost Scientific Creativity, Review Finds (Analytical Cannabis)

• NFTs Are Getting Psychedelic. Is It Worth the Trip? (Lucid News)

• Michigan moves to outlaw fake urine as marijuana popularity soars (MLive)

6.24.22

Cannabis

• Psychosis, Addiction, Chronic Vomiting: As Weed Becomes More Potent, Teens Are Getting Sick (The New York Times)

• California may require labels on cannabis products to warn of mental health risks (OPB)

• Vets And Medical Cannabis: It’s The Least We Can Do (Forbes)

• Louisiana: Multiple Marijuana Reform Bills Signed Into Law; Measures Take Effect August 1 (NORML)

• Spain Approves Medical Cannabis Reform: Pharmacy Dispensation Planned for End of 2022 (High Times)

• Medical Marijuana Legalization Linked To Reduced Drunk Driving And Safer Roads, Study On Auto Insurance Data Suggests (Marijuana Moment)

• Switzerland to Lift Ban on Medical Cannabis (High Times)

• DEA Marijuana Busts Increased In 2021, Seizing Over 5.5 Million Plants (Marijuana Moment)

• U.S. English Teacher Sentenced to 14 Years in Russia for Pot ‘Smuggling’ (High Times)

• North Carolina House Republicans Block Senate-Passed Medical Marijuana Bill (Marijuana Moment)

• Cannabis ‘Very Promising’ as Opioid Replacement, Early Study Results Show (High Times)

• U.S. Supreme Court Denies Medical Marijuana Workers’ Compensation Cases (Marijuana Moment)

• Study Shows Cannabis Use Could Lead to Increased Kindness and Empathy (High Times)

• Senate Committee Votes To Let People Who’ve Used Marijuana Work For CIA, NSA And Other Intelligence Agencies (Marijuana Moment)

• Analyses: Drug Interdiction Efforts at US Borders Typically Yield Only Small Quantities of Marijuana (NORML)

• MLB Teams Can Now Be Sponsored By CBD Companies, Baseball League Official Says (Marijuana Moment)

• Mississippi Supreme Court Upholds Life Sentence for Weed Possession (High Times)

• Scientists find little evidence to show cannabis oils help end pain, according to major study (Daily Mail)

• District of Columbia: Council Advances Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

• New Gene Technology Allows Growers To Boost THC Levels In Cannabis (Forbes)

LSD

• ‘I’m happier now and nowhere near as intense’: GoDaddy.com’s founder pivots to LSD (The Daily Dot)

Magic Mushrooms

• Judges Deny Challenge to Psilocybin Patent (VICE)

• COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting (Psychedelic Alpha)

• Pa. bill to study of psilocybin – the drug in magic mushrooms – as mental health treatment languishes in Harrisburg (PhillyVoice)

• Oregon County Considers Banning Legalized Psilocybin Therapy (Filter)

• How an NHL Enforcer Broke His Body — and Turned to Psychedelics to Heal His Brain (Rolling Stone)

MDMA

• MDMA trials under review in Canada over alleged abuse of study participants (The Guardian)

• Canadian Firm Seeks Approval to Manufacture MDMA and Other Psychedelics (High Times)

DMT

• DMT is Effective at Treating Depression, New Study Finds (Psychedelic Spotlight)

• What do we see when dying? How a psychedelic trip can trigger at life’s end, and why we need to be better prepared for it (South China Morning Post)

Ayahuasca

• An Ayahuasca Retreat Claims to Sell 'Miracles.' Former Workers and Guests Say It's Unsafe and Abusive. (VICE)

• Another Phoenix Church Sues DEA Over Religious Use of Ayahuasca (Phoenix New Times)

• The Ayahuasca King's Last Tour (The Texas Observer)

Ketamine

• Tripping Through Motherhood: How Some Women Are Using Ketamine to Treat Postpartum Depression (Glamour)

• Exploring Ketamine’s Antimicrobial Effects & Fungal Sources: Part 2 (Psychedelic Science Review)

Miscellaneous

• After Six-Decade Hiatus, Experimental Psychedelic Therapy Returns to the V.A. (The New York Times)

• Two psychedelic-related initiatives may be on the 2022 Colorado ballot (The Denver Channel)

• Alliance launches to advance psychedelic healthcare in Europe (Psychedelic Health)

• After Six-Decade Hiatus, Experimental Psychedelic Therapy Returns to the V.A. (The New York Times)

• States are embracing psychedelics, paving the way for FDA approval (DoubleBlind)

• Rabbi Ben Gorelick Plans to Use Religious Freedom Against an 8-Year Minimum Psychedelic Charge (High Times)

• Numinus Applies for International Patent Filing of Psychedelics Production Process (Psychedelic Alpha)

• The New Psychedelic Plot (The Wall Street Journal)

• Efforts to Decriminalize Psychedelics Can Extend to Rural Places, Too (The Daily Yonder)

• Recreational psychedelics remain far behind on legalization path (Pique Newsmagazine)

• Psychedelic Therapy Will Not Save Us (Mad in America)

• Mummies who mushroom: The mums using psychedelics to take the edge off modern parenthood (Harpers Bazaar)

• Extending the Reach of Psychedelic Therapy With Psychoplastogens (Technology Networks)

• The Great Microdosing Debate (Psychedelic Spotlight)

• Celebrating the Psychedelic Dawn (Lucid News)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.10.21

Cannabis

• New Study Determines Correlation Between Cannabis and Sleep (High Times)

• Marijuana banking legislation stripped from federal defense spending bill (Marijuana Business Daily)

• San Francisco delays cannabis tax so that dispensaries can compete with illegal dealers (Boing Boing)

• Costa Rica’s Constitutional Court Approves Cannabis Legalization Bill (High Times)

• World’s largest THC-infused brownie weighs in at 850 pounds (Leafly)

• CBD Products Commonly Flagged by FDA for Making Unsubstantiated Claims About Treating COVID-19 (NORML)

• Luxembourg Publishes Details on Domestic Recreational Cannabis Plan (High Times)

• Montana Lawmakers Reject Marijuana Rules, Weeks Ahead Of Legal Sales Launch (Marijuana Moment)

• Allowing Legal Marijuana Dispensaries Boosts Employment Rates In Colorado Counties, Study Finds (Marijuana Moment)

• Missouri Police Couldn’t Use Marijuana Odor To Justify Searches Under New Bill (Marijuana Moment)

• Ohio GOP Lawmakers File New Marijuana Legalization Bill (Marijuana Moment)

• Indiana GOP Lawmaker Plans Medical Marijuana Bill As Democrats Push Full Recreational Legalization (Marijuana Moment)

• Virginia Lawmakers Tout Benefits Of Psychedelics As Activists Prepare Push For Statewide Reform (Marijuana Moment)

• Producing Cannabis Biomass Without Growing A Cannabis Plant: How One Company Is Doing It (Forbes)

• Hemp Sourced Lignin for Grid Backup Batteries (Drug WarRant)

Magic Mushrooms

• COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression (Psilocybin Alpha)

• Psilocybe allenii: The Bay Area Shroom No One Can Recognize (DoubleBlind)

• Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting (Psilocybin Alpha)

• Psirenity Announces Exclusive Licence Agreement for Psilocybin (PR Newswire)

MDMA

• Did the Cult From 'Wild Wild Country' Introduce MDMA to Ibiza? (VICE)

• Can MDMA Increase Women’s Sexual Desire? (DoubleBlind)

DMT

• Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2 (Yahoo!)

Ayahuasca

• Instagram decision to remove ayahuasca post overturned by Meta Oversight Board (The Verge)

• Chacruna Institute Publishes New Book on Ayahuasca Healing and Science (Chacruna)

Peyote

• The Ancient Tradition Of The Peyote Ceremony (Benzinga)

Iboga

• U.S. Government Will Test Ibogaine Derivative As An Addiction Treatment (Forbes)

Novel Psychoactive Substances

• BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression (GlobeNewswire)

• Psilera Confirms PSIL-002, A New DMT Derivative, is Well-Tolerated and Non-Hallucinogenic from In Vivo Behavioral Studies (Psilocybin Alpha)

Ketamine

• Evidence Inconclusive for Ketamine as Bipolar Depression Treatment (Psychiatry Advisor)

Miscellaneous

• Middle-class drug users could lose UK passports under Boris Johnson’s plans (The Guardian)

• Toronto Asks Feds to Decriminalize All Drugs (Truffle Report)

• United Nations Panel Rejects International Kratom Ban (Marijuana Moment)

• New Zealand to ban smoking for next generation in bid to outlaw habit by 2025 (The Guardian)

• The Future is Research: UK Government Publishes 10-Year Drug Strategy - Drug Science Responds (Drug Science)

• Horizons 2021: Creating the future of psychedelics (The Psychedelic Renaissance)

• Report finds Instagram makes it easy for teens to find drugs online (Engadget)

• ‘Magic' Mushrooms, Ecstasy, Other Psychedelics Could Become Legal in California (NBC San Diego)

• The Wild World of 19th Century Psychedelics (Psychedelics Today)

• People Changed the Ways They Use Drugs During the Pandemic (Filter)

• You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study Shows (Psychedelic Spotlight)

• Study suggests psychedelics promote positive mental health through increased spirituality and emotion regulation (PsyPost)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Pharmacology (Psychedelic Science Review)

• 40 under 40 Outstanding BIPOC leaders in Drug Policy (DoubleBlind)

• Taking Microdosing with a Pinch of Salt (Lucid News)

• Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA) to Advance Research on Non-Hallucinogenic Therapies to Treat Substance Use Disorders (Yahoo!)

• Nue Life announces donations to Multidisciplinary Association for Psychedelic Studies and Ketamine Research Foundation (PR Newswire)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Nature (Psychedelic Science Review)

• atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual property portfolio and strengthen atai’s supply chain (Psilocybin Alpha)

• Shaman Claus: The Shamanic Christmas Origins (Reality Sandwich)

• Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer's License Application (Yahoo!)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.24.21

Cannabis

• Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

• U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

• Green Party in Finland Calls for End of Prohibition (High Times)

• This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

• California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

• Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

• Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

• Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

• Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

• VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

• Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

• FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

• Former Massachusetts Mayor Sentenced for Extortion (High Times)

• Controlling cannabis and the classification of Delta-8 THC (Reuters)

• Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

• Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

• For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

• Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

• Can Cannabis Help Your Gut? (TIME)

• Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

• Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

• Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

• Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

• Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

• Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

• Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

• Shroom Delivery is Now a Thing (DoubleBlind)

• Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

• Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

• Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

• Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

• The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

• MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

• Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

• Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

• Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

• I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

• Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

• Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

• DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

• Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

• Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

• Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

• Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

• Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

• Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

• Spice is significantly more harmful than marijuana (International Business Times)

• New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol (Yahoo! Finance)

Nitrous Oxide

• TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

• Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

• Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

• Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

• Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

• Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

• Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

• Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

• Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

• Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

• Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

• More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

• The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

• Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

• Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

• How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

• Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

• Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

• Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

• Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

• Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

• The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

• ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.19.20

Cannabis

• Louisiana Governor Signs Medical Marijuana Expansion Into Law (Marijuana Moment)

• Pennsylvania: Supreme Court Rules That Medical Cannabis Use Is Permissible While on Probation (NORML)

• New Jersey Assembly Approves Marijuana Decriminalization Bill Ahead Of Legalization Referendum (Marijuana Moment)

• Switzerland releases details on recreational marijuana experiment, but full legalization likely years away (Marijuana Business Daily)

• Nevada Pardons More Than 15,000 People With Marijuana Convictions Under Governor’s Resolution (Marijuana Moment)

• Nebraskans hustle to get medical legalization on ballot, with July 3 deadline (Leafly)

• Science Reveals The Cannabis Industry’s Greatest Lie: You’re Buying Weed Wrong (And So Is Everyone Else) (Forbes)

• Ohio Marijuana Activists Plan Supreme Court Appeal After Federal Judges Deny Electronic Signature Case (Marijuana Moment)

• Using cannabis during pregnancy could be bad news for your baby: new research (The Conversation)

• Library Of Congress Highlights Racist News Coverage Used To Justify Criminalizing Marijuana A Century Ago (Marijuana Moment)

• Patients Who Use Medical Cannabis Report Being Happier and Healthier Than Those Who Don’t (Grit Daily News)

• Fed report urges doctors to treat cannabis users as drug addicts (Leafly)

• Colorado Governor Could Issue Marijuana Pardons Under Social Equity Bill Lawmakers Sent To His Desk (Marijuana Moment)

• Cannabis Can Increase Intimacy and Reduce Anxiety During Sex, New Study Finds (MERRY JANE)

• CDC Flooded With Comments On Marijuana And Kratom As Alternative Painkillers Ahead Of Deadline (Marijuana Moment)

• These 3 Marijuana Nonprofits Are Offering Real Responses To The Pandemic And Racial Injustice (Green Entrepreneur)

• A Founder Looks at 50: The Important Role of Medical Experts in Support of Legalization (NORML)

• Lawmakers Push USDA To Let Hemp Farmers Access Coronavirus Relief Funds (Marijuana Moment)

• Why the Cannabis Sector May be Turning a New Leaf (Investopedia)

Magic Mushrooms

• Combining therapy with the psychedelic drug psilocybin results in large reductions in anxiety and depression (PsyPost)

• Colorado Activists Likely To Pursue 2022 Psilocybin Ballot Measure After Poll Shows Support (Marijuana Moment)

• Numinus receives Health Canada OK for mushrooms research (PressReader)

• Palliative Canadians endure punishing waits while Health Minister delays approval of Psilocybin mushrooms; TheraPsil expands effort to Ontario (Globe Newswire)

• A Deep Dive Inside Oregon’s Path to Legalizing Psilocybin Therapy (DoubleBlind)

• Life Sciences Firm Expands Collaboration Efforts with Major US University to Develop Psilocybin-Based Medicines (StreetWise Reports)

• New Wave Holdings Corp- Launching the first publicly-traded Psilocybin-growing operation (Value the Markets)

• Cannabis Company Eyes Medicinal Magic of Mushrooms (Real Money)

• Psilocybin to Treat Anxiety and Depression in Cancer Patients (Psychedelic Science Review)

• Cute as Children, but Not Handsome as Adults: María Sabina, Life Magazine, and Cold War Propaganda (Chacruna)

DMT

• MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration (BioSpace)

• NeonMind Files Patent Application for Therapeutic Use of DMT (Yahoo! Finance)

Ayahuasca

• Is Ayahuasca Possibly Less than Five Hundred Years Old? (Chacruna)

Iboga

• Could ibogaine offer a revolutionary long-term solution to addiction? (Health Europa)

Synthetic Cannabinoids

• New K2 Compound in Canadian Heroin Supply Amid Surging Fatal ODs (Filter)

Nitrous Oxide

• Nitrous oxide use among young people is increasing in lockdown because it’s cheap and accessible (iNews)

Ketamine

• Why People are Using Ketamine Nasal Spray to Party (DoubleBlind)

• High Doses of Ketamine Can Temporarily Shut Down the Brain, Study Finds (MERRY JANE)

• Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals (Globe Newswire)

Miscellaneous

• UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines (Psychedelic Science Review)

• Microsoft reportedly tried to sell facial recognition tech to the DEA (Engadget)

• Mira X Acquisition Corp. Announces Proposed Qualifying Transaction with Field Trip Psychedelics Inc. (Yahoo! Finance)

• Fixing American policing also requires an end to the war on drugs (Baker Institute Blog)

• Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out (Globe Newswire)

• CFN Enterprises Launches Premier Psychedelics Stock Index Site: PsyIndex.com (Stockhouse)

• Beyond Stigma: How Researchers May Trigger Drug Users (Filter)

• Psychedelics Quickly Creating a Potential $100 Billion Market Opportunity (Baystreet)

• New Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board (PR Newswire)

• Seed crystal: on the contributions of Alexander Shulgin to the science of consciousness (Medium)

• Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa (Yahoo! Finance)

• Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH (MarketWatch)

• L’Chaim Psilocybin: How Psychedelics are Reigniting Judaism (DoubleBlind)

• Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp. (Yahoo! Finance)

• 2nd Gen Psychedelic Drugs For Depression Can Be Safer For Older Adults (Forbes)

• ‘Canada’s first psychedelic-enhanced psychotherapy centre’ changing how we treat depression (GlobalNews)

• Don’t Get Caught in a Trip Trap; Psychedelic Lessons for this Collective Moment (Lucid News)

• How psychedelic drugs could help our veterans (9News)

• Pure Extracts: The Second Wave of Psychedelic Operators (The Deep Dive)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychoactives - 3.20.20

Cannabis

• Amid Coronavirus, San Francisco, New York, Deem Marijuana Businesses 'Essential' (NPR)

• Dutch queue for cannabis as coronavirus closes cafes (FRANCE 24)

• Cannabis cafes can offer takeaways to head off the return of street dealers (DutchNews.nl)

• 'The legal stuff is garbage': why Canada's cannabis black market keeps thriving (The Guardian)

• Colorado Just Issued The First Marijuana Delivery License In The State (Marijuana Moment)

• Medical Marijuana Doctors Can't Use Telemedicine During Virus Outbreak (Westword)

• Legalizing Marijuana Increases Housing Prices, Study Finds (Marijuana Moment)

• CBD Alone Can Treat Depression and Break Drug Addictions, Case Study Shows (MERRY JANE)

• Connecticut Residents Strongly Support Legalizing Marijuana, Poll Shows (Marijuana Moment)

Magic Mushrooms

• California Psilocybin Legalization Activists Request Online Signature Gathering Amid Coronavirus (Marijuana Moment)

• Study Indicates the Magic Mushroom Compound Baeocystin is Not Psychedelic (Psychedelic Science Review)

• Hawaii Lawmakers Introduce Plan To Study Psychedelic Mushrooms With Goal Of Legalizing Access (Marijuana Moment)

• Scientists Solve Another Crystal Structure of the Psilocybin Analog Miprocin, 4-HO-MiPT (Psychedelic Science Review)

• Study Shows Norpsilocin is More Potent Than Psilocin at 5-HT2A (Psychedelic Science Review)

• A Hockey Player Blamed Shrooms for His Brutal Attack on a Woman. It Worked (VICE)

Ayahuasca

• What Are the Coronavirus Risks with Ayahuasca Ceremonies? (EntheoNation)

Peyote

• Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives (Psymposia)

Opioids

• Coronavirus Is Leading to Shortages of Fentanyl And Meth (VICE)

Cocaine

• Fiona Apple quit cocaine after ‘excruciating’ night with Quentin Tarantino (Page Six)

Nicotine

• JUUL Tricks Its Customers Into Advocating for the Florida Flavor Ban (Vaping360)

• A Scientist Persuaded Italy to Exempt Vape Shops From COVID-19 Lockdown (Filter)

• Ireland bans menthol cigarettes and rolling tobacco starting May 20 (Euronews)

• Young adults don't know what's in nicotine products they vape, study finds (Medical Xpress)

• Minimum price for tobacco could boost health of poorer people, study suggests (BT)

• British American Tobacco circumventing ad ban, experts say (The Guardian)

Alcohol

• States Boost Hospitality Industry With Booze Delivery and Takeout Sales (U.S. News and World Report)

• So Alcoholics Anonymous Is “Proven” to Work After All? Not So Fast (Filter)

Kratom

• Kentucky Poison Control Center Officials Call Kratom A Drug of Concern (Kratom Guides)

Kava

• Kava consumption banned in all police premises (The Fiji Times)

Khat

• Governor Bans Sale of Miraa Over Coronavirus Fears (Kenyans.co.ke)

Miscellaneous

• Harm Reduction in the Time of Coronavirus (Medium)

• Baltimore To End Most Drug Prosecutions Amid Coronavirus Outbreak (Marijuana Moment)

• ‘Business Is Booming’ for Drug Dealers Who Deliver (The Daily Beast)

• 'Dosed' Review: The Case for Plant-Based Recovery (The New York Times)

• Myths and Realities About the Decriminalization of Psychedelics in the US (Chacruna)

• Safe injection sites: Coronavirus underlines why they make sense (New York Daily News)

• Microdosing or Using Psychedelics? How to Support Academic Research (Medium)

• Prohibition Partners Releases PSYCH: The Psychedelics as Medicine Report (Prohibition Partners)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychoactives" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Image by Psychedelic Astronaut.